This is most likely a result of GLP-1 receptor agonists producing the desired effect, weight loss, as opposed to a direct effect of GLP-1 receptor agonists on reduced gallbladder emptying or suppression of cholecystokinin, which has been hypothesized
Why is gradual dose titration important
Lose Real Weight, Sustainably Drop 515% of your body weight over time & keep it off
doi: 10.3389/fimmu.2022.905423 200 HobeikaCMukkalaANWangKPollmannNGaneshSCalderon NovoaFet al
GLP1, glucagonlike peptide1
After a single intravenous (IV) administration, single intramuscular (IM) administrations at three doses in successive increments along with repeated IM administrations, the elimination half-life (t 1/2 ) of prototype BPC157 was less than 30 min, and BPC157 showed linear pharmacokinetic characteristics in rats and beagle dogs at all doses